Journal of the American College of Surgeons
Volume 207, Issue 2 , Pages 233-239 , August 2008

Preoperative Shower Revisited: Can High Topical Antiseptic Levels Be Achieved on the Skin Surface Before Surgical Admission?

Received 13 November 2007 ,Revised 30 November 2007 ,Accepted 14 December 2007.

References 

  1. Mangram AJ, Horan TC, Pearson ML, et al. The Hospital Infection Control Practice Advisory Committee, Guidelines for the prevention of surgical site infections. Am J Infect Control. 1999;27:97–132
  2. Webster J, Osborne S. Preoperative bathing or showering with skin antiseptics to prevent surgical site infection. Cochrane Database Syst Rev. 2007;18(2):CD004985. Review
  3. Aly R, Maibach HI. Comparative antibacterial efficacy of a 2-minute surgical scrub with chlorhexidine gluconate, povidone iodine and chloroxylenol sponge-brushes. Am J Infect Control. 1988;16:173–177
  4. Maki DG, Ringer M, Alavardo CJ. Prospective, randomized trial of povidone iodine, alcohol and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet. 1991;338:339–343
  5. Crawford AG, Fuhr JP, Rao B. Cost-effective analysis of chlorhexidine gluconate dressing in prevention of catheter-related bloodstream infections. Infect Control Hosp Epidemiol. 2004;25:668–674
  6. Grabsch EA, Mitchell DJ, Hooper J, Turnidge JD. In-use efficacy of a chlorhexidine in alcohol surgical rub: a comparative study. ANZ J Surg. 2004;74:769–772
  7. DeRiso AJ, Ladowski JS, Dillon TA, et al. Chlorhexidine gluconate 0.12% oral rinse reduces the incidence of total nosocomial respiratory infection and nonprophylactic systemic antibiotic use in patients undergoing heart surgery. Chest. 1996;109:1556–1561
  8. Hibbard JS, Mulberry GK, Brady AR. A clinical study comparing the skin antisepsis and safety of ChloroPrep, 70% isopropyl alcohol, and 2% aqueous chlorhexidine. J Infus Nurs. 2002;25:244–249
  9. Vernon MO, Hayden MK, Trick WE, et al. Chlorhexidine gluconate to cleanse patients in a medical intensive care unit. Arch Intern Med. 2006;166:306–321
  10. Paulson DS. Chlorhexidine gluconate. In:  Paulson DS editors. Handbook of topical antimicrobials: industrial applications in consumer products and pharmaceuticals. New York: Marcel Dekker; 2003;p. 117–122
  11. Edmiston CE, Seabrook GR, Johnson CJ, et al. Comparative of a new and innovative 2% chlorhexidine gluconate-impregnated cloth with 4% chlorhexidine gluconate as topical antiseptic for preparation of the skin prior to surgery. Am J Infect Control. 2007;35:89–96
  12. Murray PR, Baron EJ, Jorgensen JH, et al. Manual of clinical microbiology. 9th ed.. Washington, DC: American Society for Microbiology; 2007;
  13. National Committee for Clinical Laboratory Standards. Method for dilution antimicrobial susceptibility testing for bacteria that grow aerobically. 5th ed.. Wayne, PA: National Committee for Clinical Laboratory Standard; 2000;Approved standard. NCCLS publication M7-A5
  14. The USP Official Monograph for the identification of chlorhexidine gluconate solution (The United States Pharmacopeia (USP 29), The National Formulary (NF 24)). In: Rockville, MD: The United States Pharmacopeia Convention; 2006;p. 477–478
  15. Seal LA, Paul-Cheadle P. A systems approach to preoperative surgical patient skin preparation. Am J Infect Control. 2004;32:57–62
  16. Magera JS, Inman BA, Elliott DS. Does preoperative antimicrobial scrub reduce positive surgical site culture rates in men undergoing artificial urinary sphincter placement. J Urol. 2007;178:1328–1332
  17. Cantlon CA, Stemper MF, Schwan WR, et al. Significant pathogens isolated from a community hospital in the Midwest. Am J Infect Control. 2006;34:526–529
  18. Kourbatova EV, Halvosa JS, King MD, et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus SA clone 300 as a cause of healthcare-associated infections among patients with prosthetic joint infections. Am J Infect Control. 2005;33:385–391
  19. Watters K, O'Dwyer TP, Rowley H. Cost and morbidity of MRSA in head and neck cancer patients: what are the consequences?. J Laryngol Otol. 2004;118:694–699
  20. Morange-Saussier V, Giraudeau B, van der Mee N, et al. Nasal carriage of methicillin-resistant Staphylococcus aureus in vascular surgery. Ann Vasc Surg. 2006;20:767–772
  21. Nixon M, Jackson B, Varghese P, et al. Methicillin-resistant Staphylococcus aureus on the orthopaedic wards: incidence, spread, mortality, cost and control. J Bone Joint Surg Br. 2006;88:812–817

 Disclosure Information: The following disclosure has been reported by the author: Dr Edmiston received an unrestricted research grant as an investigator for Sage Products, Inc. No one derived personal compensation from this grant. The grant was used, in part, to purchase supplies such as the 4% CHG and the 2% CHG cloths along with other material used in the study. These monies were also used to support other research activities in the laboratory that are not related to any skin-prepping product.This study was also supported by monies from our Surgical Microbiology Research Laboratory Fund, a separate independent fund administered by the Department of Surgery, Medical College of Wisconsin that is used for research support.

PII: S1072-7515(08)00177-4

doi: 10.1016/j.jamcollsurg.2007.12.054

Journal of the American College of Surgeons
Volume 207, Issue 2 , Pages 233-239 , August 2008

Article Tools

* Image Usage & Resolution